4//SEC Filing
Congleton Jon 4
Accession 0001933414-25-000129
CIK 0001933414other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 7:04 PM ET
Size
7.2 KB
Accession
0001933414-25-000129
Insider Transaction Report
Form 4
Congleton Jon
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-10-13$43.03/sh−1,552$66,782→ 831,305 total - Sale
Common Stock
2025-10-13$42.63/sh−13,548$577,544→ 832,857 total
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.9800 to $42.9800. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
- [F3]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.9822 to $43.2030. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
Documents
Issuer
Mineralys Therapeutics, Inc.
CIK 0001933414
Entity typeother
Related Parties
1- filerCIK 0001644975
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 7:04 PM ET
- Size
- 7.2 KB